Literature DB >> 7308277

Relative activities of atenolol and metoprolol on the cardiovascular system of man.

J D Harry, J M Cruickshank, J Young, N Barker.   

Abstract

The effects or oral atenolol (100 mg once/day) and metoprolol (100 mg once/day, 100 mg twice/day and 300 mg once/day) have been compared with placebo on the heart rate and systolic blood pressure responses to exercise in 5 healthy volunteers. The drugs were given for 5 days in a double blind randomised fashion with each volunteer receiving each dose of drug. Measurements were made after the first dose on day 1 and after 5 days of dosing. The results on both heart rate and systolic blood pressure showed that overall (over a 24 h period) after acute (day 1) or after chronic (5 days) dosing, atenolol 100 mg once/day, metoprolol 100 mg twice/day and 300 mg once/day, were equivalent as beta-adrenoceptor blocking doses. Thus milligram for milligram atenolol and metoprolol do not produce equivalent blockade on the cardiovascular system of man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308277     DOI: 10.1007/bf00554660

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  The effects of time on the activity of beta-adrenoceptor blocking drugs [proceedings].

Authors:  J D Harry; H F Marlow; A G Shields
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

2.  Metabolism of atenolol in man.

Authors:  P R Reeves; J McAinsh; D A McIntosh; M J Winrow
Journal:  Xenobiotica       Date:  1978-05       Impact factor: 1.908

3.  Relative activity of atenolol and metoprolol.

Authors:  J H Barber
Journal:  Br Med J       Date:  1978-07-29

4.  Beta-blockers: once or three times a day?

Authors:  T Reybrouck; A Amery; R Fagard; P Jousten; P Lijnen; E Meulepas
Journal:  Br Med J       Date:  1978-05-27

5.  Relationship between blood level of atenolol and pharmacologic effect.

Authors:  A Amery; J F De Plaen; P Lijnen; J McAinsh; T Reybrouck
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

6.  The methodology of blood pressure recording.

Authors:  E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

Review 7.  Beta-adrenergic receptor blocking drugs in angina pectoris.

Authors:  B N Prichard
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

9.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

10.  The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.

Authors:  J D Harry; M F Knapp; R J Linden
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

View more
  1 in total

1.  Genome-Wide Meta-Analysis of Blood Pressure Response to β1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).

Authors:  Sonal Singh; Helen R Warren; Timo P Hiltunen; Caitrin W McDonough; Nihal El Rouby; Erika Salvi; Zhiying Wang; Tatiana Garofalidou; Frej Fyhrquist; Kimmo K Kontula; Valeria Glorioso; Roberta Zaninello; Nicola Glorioso; Carl J Pepine; Patricia B Munroe; Stephan T Turner; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson; Yan Gong; Rhonda M Cooper-DeHoff
Journal:  J Am Heart Assoc       Date:  2019-08-19       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.